Who
Vlad Vitoc
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, MAIA Biotechnology.
In numbers
- Trades disclosed
- 57
- Buys
- 31
- Sells
- 0
- Bought
- $777K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2022
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $100K73,000 at $1.37 | filing |
| 14 Sep 2026filed 15 Sep 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $100K73,000 at $1.37 | filing |
| 1 Jun 2026filed 2 Jun 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $101K72,700 at $1.39 | filing |
| 1 Jun 2026filed 2 Jun 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $101K72,700 at $1.39 | filing |
| 29 May 2026filed 1 Jun 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 28 Nov 2025filed 4 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $57K50,000 at $1.14 | filing |
| 28 Nov 2025filed 1 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $57K50,000 at $1.14 | filing |
| 26 Nov 2025filed 4 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $23K22,000 at $1.05 | filing |
| 26 Nov 2025filed 1 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $23K22,000 at $1.05 | filing |
| 25 Nov 2025filed 4 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $10K10,500 at $0.97 | filing |
| 25 Nov 2025filed 28 Nov 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $10K10,500 at $0.97 | filing |
| 24 Nov 2025filed 25 Nov 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $9,90010,000 at $0.99 | filing |
| 21 Nov 2025filed 25 Nov 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $1,6561,800 at $0.92 | filing |
| 14 May 2025filed 16 May 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 5 Nov 2024filed 7 Nov 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code G | $36K19,981 at $1.80 | filing |
| 5 Nov 2024filed 7 Nov 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code G | $36K19,981 at $1.80 | filing |
News
Vlad Vitoc Buys 73,000 Shares of MAIA Biotechnology (NYSEAMERICAN:MAIA) Stockdailypolitical.com · 17 Sep 2026MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.8% – Here's What HappenedMAIA · dailypolitical.com · 8 Oct 2026MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung CancerMAIA · manilatimes.net · 7 Oct 2026
1 headline in the last 90 days name Vlad Vitoc; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.